ORCID Profile
0000-0002-5689-6710
Current Organisations
Royal Brisbane and Women's Hospital
,
University of Queensland
,
Emirates Health Services
,
Ministry of health and Prevention
,
Sultan Qaboos University
,
Royal College of Physicians of Edinburgh
,
Universidad Católica San Antonio de Murcia
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Related Links
Publications
Health workforce in the United Arab Emirates: analytic point of view
Publisher: Wiley
Date: 23-09-2014
DOI: 10.1002/HPM.2198
Abstract: A strong health system is impossible without health workers who are the ultimate resource. Money and medical supplies are needed, but these inputs require an efficient workforce. Challenges with respect to human resources vary greatly between and within countries, and are associated with the political, economical, cultural and societal context of a country. Moreover, the gaps in the workforce do not generally relate to doctors but to nurses and other classes of health worker who make up the bulk of health workforce. The difficulties caused by low staff numbers are compounded by morale problems, skill imbalances and geographical maldistribution. This paper will discuss how it is difficult for the United Arab Emirates (UAE, a Middle East federation country) to wrestle effectively with the demands of a good health system, exploring how they lack the basis of health systems-motivated, trained and supported people. Additionally, we looked at how the UAE health system further challenged by negative work environment, and weak knowledge-base, out-migration and inadequate investment. At the end of our discussion, we are providing some suggestions to manage human resource problems in the UAE. Highlighting how a national workforce strategic plan is important to guide investments in human resources as the core component of strengthening the UAE national health system.
Birthweight predicts adult cardiovascular disorders: Population based cross sectional survey
Publisher: Wiley
Date: 29-07-2020
DOI: 10.1002/CLC.23419
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies
Publisher: Informa UK Limited
Date: 08-04-2021
Time to address gender inequalities against female physicians
Publisher: Wiley
Date: 10-11-2018
DOI: 10.1002/HPM.2476
Abstract: Although the health care system depends heavily on female physicians, it discriminates against women and tends to concentrate female physicians' work in lower status occupations. Gender discrimination has structural, social, and cultural dimensions. Such discrimination is perceived differently by various stakeholders and the public. In addition, there is reluctance to publicly acknowledge gender discrimination, especially in the culturally conservative Middle East region. Gender discrimination leads to underrepresentation of female physicians in leadership roles and certain specialties and hence leads to less attention and understanding of the working conditions of female physicians and their roles in the health care system. The lack of accessible data in the region regarding gender discrimination among physicians leads to stakeholders failing to recognize the existence and magnitude of this type of discrimination. This article takes up the relatively neglected issue of gender discrimination in the health care workforce among the stakeholders of the Ministry of Health and Prevention of the United Arab Emirates. Future research should explore the extent of gender discrimination among physicians and the gender remuneration gap, together with other sorts of discrimination, perception of equal opportunity, and dominant stereotypes of men and women working in health care in relation to job obligation, promotion, retention, remuneration, and education.
Birthweight predicts glomerular filtration rate in adult-life: population based cross sectional study
Publisher: Informa UK Limited
Date: 2021
Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules
Publisher: MDPI AG
Date: 10-12-2017
Guttate Psoriasis Can Present With Psoriatic Arthritis after Urinary Tract Infection: Case Report
Publisher: Openventio Publishers
Date: 30-12-2016
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
Publisher: Springer Science and Business Media LLC
Date: 2009
DOI: 10.1186/AR2668
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 c
Publisher: Elsevier BV
Date: 02-2023
Corona Virus Disease 2019 (COVID-19): Intensive Care Admission Prediction Model
Publisher: Research Square Platform LLC
Date: 17-06-2020
DOI: 10.21203/RS.3.RS-35442/V1
Abstract: Background : Identifying clinical-features or a scoring-system to predict a benefit from hospital admission for patients with COVID-19 can be of great value for the decision-makers in the health-sector. We aim to identify differences in patients' demographic, clinical, laboratory and radiological findings of COVID-19 positive cases to develop and validate a diagnostic-model predicting who will develop severe-form and who will need critical-care in the future. Methodology: Patients were classified according to their clinical state into mild, moderate, severe, and critical. All their baseline clinical data, laboratory, and radiological results were used to construct a prediction-model that can predict if the COVID-19 patients will develop a severe condition that will necessitate their ICU-admission. An ensemble feature selection tool was used to identify the relative importance of each variable. The performance of the selected features compared to all features using logistic regression and area under curve test. Results : Patients with ICU admission showed a distinct clinical, demographic as well as laboratory features when compared to pattients that did not need ICU admission. This includes elder age group, male gender and presence of comorbidities like diabetis and history of hypertension.Out of the different demographic, clinical and laboratory charasteristics of these patients, Age at diagnosis, Lymphocyte count, C-reactive protein (CRP), lactate dehydrogenase (LDH), Albumin, Urea, and Procalcitonin levels were found to be able to predict which patients may need ICU admission. Conclusion: Higher CRP, LDH, Age at diagnosis, Urea, Procalcitonin, and lower Albumin, Lymphocyte count are significant determinant in ICU admission for COVID-19 patients.
Rheumatoid arthritis: Links with cardiovascular disease and the receptor for advanced glycation end products
Publisher: Springer Science and Business Media LLC
Date: 2006
DOI: 10.1007/S10354-005-0242-9
Abstract: Cardiovascular (CV) disease is increased in patients with chronic inflammatory disease, including rheumatoid arthritis (RA). Furthermore it has become clear at a pathophysiological level, that atherosclerosis has striking similarities with autoimmune disease. This realization has come at a time of paradigm shift in how rheumatologists manage RA, with the availability of biological agents targeting key inflammatory cytokines. This review will focus on the possible causes of increased vascular disease in RA, including the role of traditional CV risk factors. Mechanisms potentially at play, such as C-reactive protein (CRP), altered coagulation, and cyclooxygenase (COX)-2 inhibitors will be covered in brief. The receptor for advanced glycation end products (RAGE) has been identified as a candidate molecule influencing response to ongoing inflammation and autoimmunity. There will be a focus on the role of RAGE in CV disease and RA. As has been the case with many novel molecules, functional polymorphisms are thought to alter disease expression and assist us in coming to terms with the biological activities of the parent molecule. The review will conclude with a discussion of the potential role of the RAGE Glycine 82 Serine polymorphism.
Male Gender is A Risk Factor For Sever Form of COVID-19 Illness and Worse Outcome in The Middle East
Publisher: Research Square Platform LLC
Date: 17-06-2020
DOI: 10.21203/RS.3.RS-35439/V1
Abstract: The identification of risk-factors, predicting the disease severity and outcome in novel coronavirus-disease-19 (COVID-19) patients, is essential to improve responsiveness to this pandemic. The association between gender and wide-range of clinical, pathological, and epidemiological factors was studied in 200-patients recruited during March-April 2020. A higher prevalence of COVID-19 infection in male (72%) compared to females (28%). Age and history of previous comorbidities were nearly comparable between genders (P value 0.75 and 0.97, respectively), male-patients had higher incidence of sever-critical form of the disease (44.67%) compared to only 23.22% in female-patients (P 0.001). A 26.39% and 1.79% of male and female patients needed Intensive-care-unit (ICU) admission(P 0.001), respectively. Male-patients developed a significant higher rate of lung injury presented as bilateral airspace consolidation in the plain chest X-ray at admission (38.89%) compared to 23.21% in female patient (P = 0.036%). A significant impairment of the renal-function (P = 0.031) and liver-function tests with higher level of lactate-dehydrogenase (LDH) (P 0.001), serum bilirubin (P 0.001), alanine-transferase ALT (P = 0.036), and aspartate-aminotransferase, AST (P = 0.022) in male patients compared to female patients. In conclusion, this is the first detailed analysis in the middle east that thoroughly investigate the role of gender in determining the clinical course and severity of COVID-19 infection. Males compared to their age matched females, with same prevalence of comorbidities were more vulnerable to the sever COVID-19 illness with higher probability for ICU admission.
Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
Publisher: Springer Science and Business Media LLC
Date: 08-07-2023
DOI: 10.1038/S41467-023-39766-X
Abstract: The safety and immunogenicity of a protein-based tetravalent vaccine SCTV01E that contains spike protein ectodomain (S-ECD) of Alpha, Beta, Delta and Omicron BA.1 are assessed and compared with bivalent protein vaccine SCTV01C (Alpha and Beta variants) and monovalent mRNA vaccine (NCT05323461). The primary endpoints are the geometric mean titers (GMT) of live virus neutralizing antibodies (nAb) to Delta (B.1.617.2) and Omicron BA.1 at day 28 post-injection. The secondary endpoints include the safety, day 180 GMTs against Delta and Omicron BA.1, day 28 GMTs to BA.5, and seroresponse rates of neutralizing antibodies and T cell responses at day 28 post-injection. 450 participants, comprising of 449 males and 1 female, with a median age (range) of 27 (18–62) years, are assigned to receive one booster dose of BNT162b2, 20 µg SCTV01C or 30 µg SCTV01E and completed 4-week follow-up. All SCTV01E related adverse events (AEs) are mild or moderate and no Grade ≥3 AE, serious AE or new safety concerns are identified. Day 28 GMT of live virus neutralizing antibodies and seroresponse against Omicron BA.1 and BA.5 with SCTV01E are significantly higher than those with SCTV01C and BNT162b2. These data indicate an overall neutralization superiority with tetravalent booster immunization in men.
Cells of the synovium in rheumatoid arthritis. Dendritic cells
Publisher: Springer Science and Business Media LLC
Date: 2007
DOI: 10.1186/AR2200
Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: A critical role for inflammation
Publisher: Springer Science and Business Media LLC
Date: 2007
DOI: 10.1186/AR2323
Klippel Trenaunay Syndrome, Inverse Klippel Trenaunay Syndrome: Hypertrophy of Lower Limbs and Atrophy of the Upper Limbs and Facial Muscles: Case Report and Literature Review
Publisher: OMICS Publishing Group
Date: 2013
Related Organisations
Royal College Of Physicians Of Edinburgh
Location: United Kingdom of Great Britain and Northern Ireland
Related Funding Activities
No related grants have been discovered for Suad Hannawi.